These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10348778)

  • 1. Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis.
    Wolf K; Malinverni R
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1491-3. PubMed ID: 10348778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice.
    Bin XX; Wolf K; Schaffner T; Malinverni R
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1761-4. PubMed ID: 10817751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.
    Malinverni R; Kuo CC; Campbell LA; Lee A; Grayston JT
    Antimicrob Agents Chemother; 1995 Jan; 39(1):45-9. PubMed ID: 7695327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jan; 42(1):194-6. PubMed ID: 9449287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin in treatment of patients with asthma and C. Pneumoniae infection.
    Dokic D; Poposki B; Karkinski D
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(2):71-7. PubMed ID: 24296633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: report of a case.
    Wang JH; Wang JH; Liu YC; Chen YS; Yen MY; Wann SR; Cheng DL
    J Formos Med Assoc; 1994 Jul; 93(7):642-4. PubMed ID: 7866068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
    Harris JA; Kolokathis A; Campbell M; Cassell GH; Hammerschlag MR
    Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia.
    Niki Y; Kimura M; Miyashita N; Soejima R
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2296-9. PubMed ID: 7840560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.
    Carter JD; Espinoza LR; Inman RD; Sneed KB; Ricca LR; Vasey FB; Valeriano J; Stanich JA; Oszust C; Gerard HC; Hudson AP
    Arthritis Rheum; 2010 May; 62(5):1298-307. PubMed ID: 20155838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents.
    Masson ND; Toseland CD; Beale AS
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1959-64. PubMed ID: 8540698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinations.
    Freidank HM; Losch P; Vögele H; Wiedmann-Al-Ahmad M
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1808-10. PubMed ID: 10390251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice.
    Törmäkangas L; Saario E; Bem David D; Bryskier A; Leinonen M; Saikku P
    J Antimicrob Chemother; 2004 Jun; 53(6):1101-4. PubMed ID: 15117927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model.
    Kutlin A; Roblin PM; Hammerschlag MR
    J Antimicrob Chemother; 2002 May; 49(5):763-7. PubMed ID: 12003969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unfortunately without effectiveness: chlamydia eradication after infarct].
    MMW Fortschr Med; 2002 Apr; 144(14):10. PubMed ID: 12014269
    [No Abstract]   [Full Text] [Related]  

  • 15. High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin.
    Worm HC; Wirnsberger GH; Mauric A; Holzer H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1890-4. PubMed ID: 15128877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.
    Gieffers J; Füllgraf H; Jahn J; Klinger M; Dalhoff K; Katus HA; Solbach W; Maass M
    Circulation; 2001 Jan; 103(3):351-6. PubMed ID: 11157684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.
    Gnarpe J; Eriksson K; Gnarpe H
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1843-5. PubMed ID: 8843291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection.
    Caronzolo D; Lucini V; Pannacci M; Grosso S; Kieffer N; Bello L; Bikfalvi A; Scaglione F
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3277-82. PubMed ID: 17005805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tulathromycin, azithromycin and azithromycin-rifampin for the treatment of mild pneumonia associated with Rhodococcus equi.
    Venner M; Credner N; Lämmer M; Giguère S
    Vet Rec; 2013 Oct; 173(16):397. PubMed ID: 24106244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.